By expenditures
| Name | Title | Type |
|---|---|---|
| Scott Wold | Business Manager | Auditee |
| James Vreeland | BUSINESS MANAGER | Auditee |
| Nick Cavaliere | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 344578 | 2024 | 2025-03-03 | Baker Tilly | $11.25M |
| 294244 | 2023 | 2024-03-08 | Baker Tilly US LLP | $22.07M |
| 37186 | 2022 | 2023-03-21 | Baker Tilly US LLP | $10.77M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 344578 | 2024 | 2025-03-03 | 1101952 | 2024-005 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101951 | 2024-005 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101950 | 2024-005 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101949 | 2024-004 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101948 | 2024-004 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101947 | 2024-004 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101946 | 2024-007 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101945 | 2024-007 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101944 | 2024-007 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101943 | 2024-006 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101942 | 2024-006 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 1101941 | 2024-006 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 525510 | 2024-005 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 525509 | 2024-005 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 525508 | 2024-005 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 525507 | 2024-004 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 525506 | 2024-004 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 525505 | 2024-004 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 525504 | 2024-007 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 525503 | 2024-007 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 525502 | 2024-007 | Significant Deficiency | - | AB |
| 344578 | 2024 | 2025-03-03 | 525501 | 2024-006 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 525500 | 2024-006 | Material Weakness | - | AB |
| 344578 | 2024 | 2025-03-03 | 525499 | 2024-006 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 950985 | 2023-003 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 950984 | 2023-003 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 950983 | 2023-003 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 950982 | 2023-003 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 374543 | 2023-003 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 374542 | 2023-003 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 374541 | 2023-003 | Material Weakness | - | AB |
| 294244 | 2023 | 2024-03-08 | 374540 | 2023-003 | Material Weakness | - | AB |
| 37186 | 2022 | 2023-03-21 | 612849 | 2022-003 | Significant Deficiency | - | AB |
| 37186 | 2022 | 2023-03-21 | 36407 | 2022-003 | Significant Deficiency | - | AB |